29 June 2021>: Clinical Research
Intermittent Theta Burst Stimulation (iTBS) for Treatment of Chronic Post-Stroke Aphasia: Results of a Pilot Randomized, Double-Blind, Sham-Controlled Trial
Jerzy P. Szaflarski 12ABDEFG* , Rodolphe Nenert 1BCDE , Jane B. Allendorfer 13BE , Amber N. Martin 1BE , Amy W. Amara 13BE , Joseph C. Griffis 14BE* , Aimee Dietz 5AE , Victor W. Mark 146DE , Victor W. Sung 1BE , Harrison C. Walker 16BE , Xiaohua Zhou 6BE , Christopher J. Lindsell 7ACEDOI: 10.12659/MSM.931468
Med Sci Monit 2021; 27:e931468
Table 1 Demographic data of stroke participants included in the analyses (N=27).
Subject | Token | Handedness | Gender | Age at scan | TSS(Y) | fMRI sessions | rTMS weeks |
---|---|---|---|---|---|---|---|
PART001 | 28 | Right | F | 79 | 3.4 | 3 | 1 |
PART002 | 33 | Right | M | 64.6 | 14 | 3 | 0 |
PART003 | 12 | Right | F | 57.8 | 13 | 3 | 2 |
PART006 | 6 | Right | M | 49.6 | 2.9 | 3 | 3 |
PART008 | 9 | Right | M | 57 | 2.1 | 3 | 2 |
PART009 | 21 | Right | M | 50.7 | 1.1 | 3 | 3 |
PART010 | 34 | Right | M | 43.1 | 1.3 | 3 | 1 |
PART011 | 6 | Right | F | 74 | 1.65 | 2 | 3 |
PART012 | 21 | Right | F | 23.8 | 2.3 | 2 | 0 |
PART013 | 10 | Right | F | 66.6 | 2.2 | 3 | 1 |
PART014 | 39 | Left | F | 61.8 | 4.4 | 3 | 3 |
PART015 | 4 | Right | M | 30 | 0.9 | 2 | 2 |
PART019 | 34 | Right | F | 43.6 | 2.2 | 3 | 0 |
PART020 | 33 | Right | M | 62.1 | 2.7 | 3 | 3 |
PART021 | 9 | Right | M | 46.4 | 1.7 | 2 | 1 |
PART022 | 23 | Right | M | 53.3 | 1.2 | 3 | 2 |
PART023 | 9 | Right | M | 54.6 | 3.7 | 3 | 0 |
PART024 | 41 | Left | M | 44.1 | 3.3 | 3 | 0 |
PART026 | 28 | Right | M | 61.1 | 9.6 | 3 | 3 |
PART027 | 24 | Right | M | 67.4 | 12.7 | 2 | 2 |
PART028 | 7 | Right | F | 78.4 | 1.9 | 2 | 1 |
PART030 | 31 | Right | M | 84.7 | 1.3 | 2 | 1 |
PART032 | 39 | Right | F | 57.2 | 1.1 | 3 | 3 |
PART033 | 27 | Right | M | 54 | 1 | 2 | 2 |
PART034 | 12 | Right | M | 47.3 | 0.9 | 3 | 1 |
PART035 | 4 | Right | M | 46.2 | 1.2 | 3 | 2 |
PART036 | 32 | Right | M | 63 | 2.2 | 3 | 0 |
TT – Token Test, TSS – Time since stroke. Based on the randomization procedure, the subjects received a variable number of active and sham TMS treatments. The number of active treatment weeks is included in the “rTMS weeks” column. |